Glucose B.Braun (Glucose Monohydrate)

Glucose B.Braun is used primarily to restore or maintain blood glucose concentrations in clinical settings where oral intake is not feasible.

• Provides rapid glucose supplementation during surgery or anesthesia.
• Supports energy needs in patients receiving total parenteral nutrition.
• Corrects hypoglycemia in emergency or critical‑care situations.
• Serves as a carrier solution for compatible intravenous medications.
• Assists in metabolic testing protocols that require controlled glucose infusion.

When administered intravenously, glucose monohydrate may be associated with a range of observed effects, most of which are related to its metabolic role.

Common

• Transient hyperglycemia
• Mild electrolyte shift (e.g., potassium)
• Local irritation at the infusion site
• Nausea or vomiting if infused rapidly

Serious

• Severe hyperglycemia leading to osmotic diuresis
• Hypersensitivity reactions such as rash or anaphylaxis
• Fluid overload in patients with compromised cardiac function
• Metabolic acidosis in cases of massive infusion

Clinicians should consider several precautionary measures before selecting Glucose B.Braun for intravenous therapy.

• Verify patient’s baseline blood glucose and adjust infusion rate accordingly.
• Assess renal and cardiac function to avoid fluid overload or electrolyte imbalance.
• Use aseptic technique to prevent catheter‑related infections.
• Avoid concurrent administration with high‑dose insulin without monitoring.
• Monitor serum electrolytes, especially potassium and phosphate, during prolonged infusion.
• Consider contraindication in patients with known hypersensitivity to glucose solutions.

Glucose B.Braun can interact with other agents administered intravenously; awareness of these interactions helps maintain safety.

Avoid

• High‑dose insulin boluses without glucose supplementation, which may precipitate severe hypoglycemia.
• Hyperosmolar dextrose solutions combined with other hypertonic fluids, increasing risk of osmotic injury.
• Medications that require a low‑glucose environment, such as certain chemotherapeutic agents, where excess glucose may reduce efficacy.

Use with caution

• Diuretics that affect electrolyte balance, requiring close monitoring of potassium.
• Calcium channel blockers, as rapid glucose infusion can influence hemodynamics.
• Blood products, because glucose can affect the stability of some components.